| abstract |
The present invention relates to a novel aptamer molecule used for treating a subject by inhibiting or suppressing TLR9 activation in a cell, and a method for inhibiting or suppressing TLR9 activation in a cell using such an aptamer molecule. , Pharmaceutical compositions and kits comprising such aptamer molecules, and the use of the aptamer molecules to inhibit or suppress TLR9 activation. [Selection diagram] Fig. 1 |